Comparison of E-Test®, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes

References

• Barchiesi F, Arzeni D, Camiletti V, et al. In vitro activity of Posaconazole against clinical isolates of dermatophytes. J Clin Microbiol 2001; 39: 4208–4209
   PubMed Web of Science ®Google Scholar
• Fernández-Torres B, Carrillo AJ, Martín E, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001; 45: 2524–2528
   PubMed Web of Science ®Google Scholar
• Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz AJ, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999–4003
   PubMed Web of Science ®Google Scholar
• Jessup CJ, Warner J, Isham N, et al. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000; 38: 341–344
   PubMed Web of Science ®Google Scholar
• Perea S, Fothergill AW, Sutton DA, et al. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001; 39: 385–388
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute /National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA 2002
   Google Scholar
• Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, et al. Intra- and interlaboratory study of a method for testing the antifungal susceptibility of dermatophytes. J Clin Microbiol 2004; 42: 2977–2979
   PubMed Web of Science ®Google Scholar
• Serrano MC, Chávez-Caballero M, Valverde-Conde A, et al. Actividad in vitro de voriconazol y otros tres antifúngicos frente a dermatofitos. Enferm Infecc Microbiol Clin 2003; 21: 484–487
   Google Scholar
• Arikan S, Paetznick V, Rex JH. Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 2002; 46: 3084–3087
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Rezusta A. E-Test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol 2002; 40: 2101–2107
   PubMed Web of Science ®Google Scholar
• Fernández-Torres B, Inza I, Guarro J. Evaluation of disk diffusion method for dermatophytes and influence of culture medium. Antimicrob Agents Chemother 2005; 49: 2116–2118
   PubMed Web of Science ®Google Scholar
• Martín-Mazuelos E, Pemán J, Valverde A, et al. Comparison of the Sensititre YeastOne colorimetric antifungal panel and E-test with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 2003; 52: 365–370
   PubMed Web of Science ®Google Scholar
• Fernández-Torres B, Carrillo-Muñoz A, Ortopeda M, et al. Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med Mycol 2003; 41: 125–130
   Google Scholar
• Carrillo-Muñoz A, Cardenes C, Carrillo-Orive B, et al. In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis. Rev Iberoam Micol 2005; 22: 110–113
   Google Scholar
• Serrano MC, Ramírez M, Morilla D, et al. A comparative study of the disc diffusion method with the broth microdilution and E-test methods for voriconazole susceptibility testing of Aspergillus spp. J Antimicrobial Chemother 2004; 53: 739–742
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute/National Committte for Clinical Laboratory Standards. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeast: Approved guideline M44-A document. National Committee for Clinical Laboratory Standards, Wayne, PA 2003
   Google Scholar
• Santos D A, Hamdan JS. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Med Mycol 2006; 44: 357–362
   PubMed Web of Science ®Google Scholar
• Carrillo-Muñoz AJ, Giusiano G, Guarro J, et al. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and others opportunistic fungi as agents of onychomicosis. Int J Antimicrob Agents 2007; 30: 157–161
   PubMed Web of Science ®Google Scholar
• Ghannoum N., Isham N., Sheehan D. Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol 2006; 44: 2579–2580
   PubMed Web of Science ®Google Scholar
• Arikan S, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother 2003; 47: 2640–2643
   PubMed Web of Science ®Google Scholar
• Esteban A, Abarca ML, Cabanes FJ. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Med Mycol 2005; 43: 61–63
   PubMed Web of Science ®Google Scholar